PEDIATRICS Vol. 98 No. 2 August 1996, pp. 301-304
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Medication for Children With Attentional Disorders

Committee on Children and Disabilities and Committee on Drugs

Increasing numbers of children with attentional difficulties have been treated with medication, especially during the last 25 years, and now adolescents and adults are also being recognized with attentional difficulties. This policy statement provides information on the role and the pharmacology of medications used to treat children with attention deficit disorders. Indications and use of medications are discussed and recommended drugs and dose levels are outlined. Information on adverse effects and common side effects is presented.


The following policy statement has been revised:

Medication for Children With an Attention Deficit Disorder
and
Pediatrics 80: 758-760.



This article has been cited by other articles:


Home page
 PediatricsHome page
R. A. Barkley, M. Fischer, L. Smallish, and K. Fletcher
Does the Treatment of Attention-Deficit/Hyperactivity Disorder With Stimulants Contribute to Drug Use/Abuse? A 13-Year Prospective Study
Pediatrics, January 1, 2003; 111(1): 97 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
R. Bussing, B. T. Zima, F. A. Gary, and C. W. Garvan
Use of Complementary and Alternative Medicine for Symptoms of Attention-Deficit Hyperactivity Disorder
Psychiatr Serv, September 1, 2002; 53(9): 1096 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Kuczenski and D. S. Segal
Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine
J. Neurosci., August 15, 2002; 22(16): 7264 - 7271.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. J. Thompson, L. Leigh, R. Christensen, X. Xiong, L. E. Kun, R. L. Heideman, W. E. Reddick, A. Gajjar, T. Merchant, C.-H. Pui, et al.
Immediate Neurocognitive Effects of Methylphenidate on Learning-Impaired Survivors of Childhood Cancer
J. Clin. Oncol., March 15, 2001; 19(6): 1802 - 1808.
[Abstract] [Full Text] [PDF]

Home page
 Arch Fam MedHome page
L. H. McCormick
Improving Social Adjustment in Children With Attention-Deficit/Hyperactivity Disorder
Arch Fam Med, February 1, 2000; 9(2): 191 - 194.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
M. D. Rappley, P. B. Mullan, F. J. Alvarez, I. U. Eneli, J. Wang, and J. C. Gardiner
Diagnosis of Attention-Deficit/Hyperactivity Disorder and Use of Psychotropic Medication in Very Young Children
Arch Pediatr Adolesc Med, October 1, 1999; 153(10): 1039 - 1045.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. Chavez, D. Ozolins, and J. D. Losek
Hypoglycemia and Propranolol in Pediatric Behavioral Disorders
Pediatrics, June 1, 1999; 103(6): 1290 - 1291.
[Full Text]

Home page
 Pediatr. Rev.Home page
K. J. Miller and F. X. Castellanos
Attention Deficit/Hyperactivity Disorders
Pediatr. Rev., November 1, 1998; 19(11): 373 - 384.
[Full Text] [PDF]

Home page
 JAMAHome page
L. S. Goldman, M. Genel, R. J. Bezman, P. J. Slanetz, and for the Council on Scientific Affairs, American Me
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
JAMA, April 8, 1998; 279(14): 1100 - 1107.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. Diller, R. Morrow;, D. J. Safer, J. M. Zito, and E. M. Fine
The Case of the Missing Methylphenidate
Pediatrics, October 1, 1997; 100(4): 730 - 730.
[Full Text] [PDF]

Home page
 PediatricsHome page
I. J. Kash;, E. R. Colson;, J. M. Perrin, G. Erenberg, and F. Member
Medication for Children With Attention Disorders
Pediatrics, June 1, 1997; 99(6): 922 - 922.
[Full Text] [PDF]